Is Dave Inc DAVE stock weaker than competitors Q4 2025 EPS Exceeds Expectations INBKZ First Internet Bancorp 60 FixedtoFloating Rate Subordinated Notes Due 2029 Q4 2025 EPS beat lifts shares 165 percent on positive sentiment SUPN Supernus Pharmaceuticals Inc delivers 142 percent Q4 2025 EPS surprise shares rise 441 percent today Korro Bio KRRO Moat Analysis Q4 2025 Earnings Beat Estimates EG Everest Group Ltd shares rise roughly 2 percent even as Q4 2025 earnings land slightly below analyst expectations Rigel Pharmaceuticals RIGL Stock Reversal Signals 090 20260416 Is Clene CLNN stock worth entering at this stage Q4 2025 EPS Misses Estimates DEI Douglas Emmett Inc posts narrower Q4 2025 loss than estimates shares climb 245 percent Carriage CSV Stock Price to Free Cash Buying Pressure 20260416 Is Sionna Therapeutics SION stock expensive relative to growth 376 20260418